Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sazani

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American Chemical Society|December 19, 2002
Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agentsKaren McAllister, Peter Sazani, Mirielle Adam, et al.
International Journal of Toxicology|May 5, 2011
Repeat-dose toxicology evaluation in cynomolgus monkeys of AVI-4658, a phosphorodiamidate morpholino oligomer (PMO) drug for the treatment of duchenne muscular dystrophyPeter Sazani, Kirk P Van Ness, Doreen L Weller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2008
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx miceNatee Jearawiriyapaisarn, Hong M Moulton, Brian Buckley, et al.
International Journal of Toxicology|May 5, 2011
Chemical and mechanistic toxicology evaluation of exon skipping phosphorodiamidate morpholino oligomers in mdx micePeter Sazani, Kirk P Van Ness, Doreen L Weller, et al.
Journal of Neuromuscular Diseases|November 18, 2016
Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human PrimatesMichael P Carver, Jay S Charleston, Courtney Shanks, et al.
Nature Biotechnology|November 12, 2002
Systemically delivered antisense oligomers upregulate gene expression in mouse tissuesPeter Sazani, Federica Gemignani, Shin-Hong Kang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse ModelsMaria A Graziewicz, Teresa K Tarrant, Brian Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse modelsMaria A Graziewicz, Teresa K Tarrant, Brian Buckley, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studiesAlison E Heald, Patrick L Iversen, Jay B Saoud, et al.
World Journal of Pediatrics : WJP|May 4, 2017
Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatmentQing Ke, Zheng-Yan Zhao, Robert Griggs, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American Chemical Society|December 19, 2002
Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agentsKaren McAllister, Peter Sazani, Mirielle Adam, et al.
International Journal of Toxicology|May 5, 2011
Repeat-dose toxicology evaluation in cynomolgus monkeys of AVI-4658, a phosphorodiamidate morpholino oligomer (PMO) drug for the treatment of duchenne muscular dystrophyPeter Sazani, Kirk P Van Ness, Doreen L Weller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2008
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx miceNatee Jearawiriyapaisarn, Hong M Moulton, Brian Buckley, et al.
International Journal of Toxicology|May 5, 2011
Chemical and mechanistic toxicology evaluation of exon skipping phosphorodiamidate morpholino oligomers in mdx micePeter Sazani, Kirk P Van Ness, Doreen L Weller, et al.
Journal of Neuromuscular Diseases|November 18, 2016
Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human PrimatesMichael P Carver, Jay S Charleston, Courtney Shanks, et al.
Nature Biotechnology|November 12, 2002
Systemically delivered antisense oligomers upregulate gene expression in mouse tissuesPeter Sazani, Federica Gemignani, Shin-Hong Kang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse ModelsMaria A Graziewicz, Teresa K Tarrant, Brian Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse modelsMaria A Graziewicz, Teresa K Tarrant, Brian Buckley, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studiesAlison E Heald, Patrick L Iversen, Jay B Saoud, et al.
World Journal of Pediatrics : WJP|May 4, 2017
Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatmentQing Ke, Zheng-Yan Zhao, Robert Griggs, et al.
Pageof 3